Studies of metabolite-protein interactions: a review.
暂无分享,去创建一个
D. S. Hage | Jeanethe A Anguizola | Ryan Matsuda | Xiwei Zheng | M. Sobansky | E. Rodriguez | Cong Bi | B. Hage | John Vargas Badilla | D. Hage | Benjamin D. Hage
[1] D. S. Hage,et al. Review: Glycation of human serum albumin. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[2] D. S. Hage,et al. Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin. , 2013, Current Metabolomics.
[3] Lu Wang,et al. Stereoselective binding of chiral drugs to plasma proteins , 2013, Acta Pharmacologica Sinica.
[4] D. S. Hage,et al. Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin , 2013, Analytical and Bioanalytical Chemistry.
[5] D. S. Hage,et al. Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin. , 2013, Analytical chemistry.
[6] Youhua Xu,et al. Pre-column incubation followed by fast liquid chromatography analysis for rapid screening of natural methylglyoxal scavengers directly from herbal medicines: case study of Polygonum cuspidatum. , 2013, Journal of chromatography. A.
[7] Philip Britz-McKibbin,et al. New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. , 2013, Chemical reviews.
[8] D. S. Hage,et al. Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin. , 2012, Journal of chromatography. A.
[9] M. Snyder,et al. Investigating metabolite-protein interactions: an overview of available techniques. , 2012, Methods.
[10] V. Trezza,et al. Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.
[11] G. Siuzdak,et al. Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.
[12] D. S. Hage,et al. Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography , 2012, Analytical and Bioanalytical Chemistry.
[13] Caroline H. Johnson,et al. Xenobiotic metabolomics: major impact on the metabolome. , 2012, Annual review of pharmacology and toxicology.
[14] D. S. Hage,et al. Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling. , 2011, Journal of chromatography. A.
[15] D. S. Hage,et al. High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin , 2011, Analytical and bioanalytical chemistry.
[16] D. S. Hage,et al. CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME. , 2011, Analytical methods : advancing methods and applications.
[17] Michael J. Kimzey,et al. New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. , 2011, Chemico-Biological Interactions.
[18] D. S. Hage,et al. Characterization of drug interactions with serum proteins by using high-performance affinity chromatography. , 2011, Current drug metabolism.
[19] Jeffrey M Peters,et al. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[20] D. S. Hage,et al. Binding of tolbutamide to glycated human serum albumin. , 2011, Journal of pharmaceutical and biomedical analysis.
[21] D. S. Hage,et al. Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] Kevin Y. Yip,et al. Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses , 2010, Cell.
[23] Liang-Hong Guo,et al. Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins. , 2010, Toxicology.
[24] D. S. Hage,et al. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. , 2010, Journal of pharmaceutical and biomedical analysis.
[25] D. S. Hage,et al. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[26] Benjamin P Bowen,et al. Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging. , 2010, BioTechniques.
[27] J. Ramos,et al. Compartmentalized Glucose Metabolism in Pseudomonas putida Is Controlled by the PtxS Repressor , 2010, Journal of bacteriology.
[28] D. S. Hage,et al. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[29] Julie Schappler,et al. Drug–protein binding: a critical review of analytical tools , 2010, Analytical and bioanalytical chemistry.
[30] Thomas Hoffmann,et al. CE‐ESI‐MS/MS as a rapid screening tool for the comparison of protein–ligand interactions , 2010, Electrophoresis.
[31] W. Zheng,et al. The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro. , 2010, Journal of veterinary pharmacology and therapeutics.
[32] A. Stokes,et al. Online quench-flow electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for elucidating kinetic and chemical enzymatic reaction mechanisms. , 2010, Analytical chemistry.
[33] D. S. Hage,et al. Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography. , 2010, Analytical biochemistry.
[34] Hao Sun,et al. Structure‐based Drug Metabolism Predictions for Drug Design , 2010, Chemical biology & drug design.
[35] M. D. de Groot,et al. Understanding CYP2D6 interactions. , 2009, Drug discovery today.
[36] John E. Schiel,et al. Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. , 2009, Journal of chromatography. A.
[37] D. S. Hage,et al. Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography. , 2009, Journal of separation science.
[38] I. Wainer,et al. Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC). , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[39] Hideyuki Suzuki,et al. Characterization of orphan monooxygenases by rapid substrate screening using FT-ICR mass spectrometry. , 2008, Chemistry & biology.
[40] N. Lopes,et al. Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis , 2008, Analytical and bioanalytical chemistry.
[41] A. Foroumadi,et al. Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[42] R. Weinshilboum,et al. Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.
[43] D. J. Veldhuisen,et al. Advanced glycation end‐products (AGEs) and heart failure: Pathophysiology and clinical implications , 2007, European journal of heart failure.
[44] F. B. Davis,et al. Molecular modeling of the thyroid hormone interactions with αvβ3 integrin , 2007, Steroids.
[45] F. Ceciliani,et al. The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. , 2007, Current protein & peptide science.
[46] Anne Hersey,et al. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. , 2006, Journal of medicinal chemistry.
[47] M. Otagiri,et al. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. , 2006, Journal of molecular biology.
[48] K. Comess,et al. An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF , 2006, Journal of biomolecular screening.
[49] S. Curry,et al. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.
[50] G. Cooper,et al. A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[51] D. S. Hage,et al. Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[52] Harald Schwalbe,et al. Biomolecular NMR: a chaperone to drug discovery , 2006, Current Opinion in Chemical Biology.
[53] Fernand Labrie,et al. Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity , 2006, Protein science : a publication of the Protein Society.
[54] Harald Schwalbe,et al. NMR characterization of kinase p38 dynamics in free and ligand-bound forms. , 2006, Angewandte Chemie.
[55] S. Curry,et al. Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] Andrea Giachetti,et al. Combining in silico tools and NMR data to validate protein-ligand structural models: application to matrix metalloproteinases. , 2005, Journal of medicinal chemistry.
[57] Mahavir Singh,et al. Monitoring the effects of antagonists on protein-protein interactions with NMR spectroscopy. , 2005, Journal of the American Chemical Society.
[58] U. Karst,et al. Monitoring enzymatic conversions by mass spectrometry: a critical review , 2005, Analytical and bioanalytical chemistry.
[59] John E. Schiel,et al. Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: studies using free thyroxine as a model system. , 2005, Analytical chemistry.
[60] Philip Doble,et al. Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[61] David R. Liu,et al. In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[63] D. S. Hage,et al. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[64] N. Pohl,et al. Discovery of the chemical function of glycosidases: design, synthesis, and evaluation of mass-differentiated carbohydrate libraries. , 2004, Organic letters.
[65] Lee Makowski,et al. RELIC – A bioinformatics server for combinatorial peptide analysis and identification of protein‐ligand interaction sites , 2004, Proteomics.
[66] R. Falchetto,et al. SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of orphan protein ligands. , 2004, Analytical biochemistry.
[67] M. Sugawara,et al. Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants. , 2003, British journal of clinical pharmacology.
[68] Stephen Naylor,et al. Parallel determination of multiple protein metabolite interactions using cell extract, protein microarrays and mass spectrometric detection. , 2003, Rapid communications in mass spectrometry : RCM.
[69] R. Palmer,et al. X-ray crystallographic studies of protein-ligand interactions. , 2003, Biochemical Society transactions.
[70] S. Todo,et al. Age- and gender-related differences in carbohydrate concentrations of α1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities , 2002, European Journal of Clinical Pharmacology.
[71] Manfred Kansy,et al. Predicting plasma protein binding of drugs: a new approach. , 2002, Biochemical pharmacology.
[72] M. Otagiri,et al. How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin? , 2002, Pharmaceutical Research.
[73] Carlo Bertucci,et al. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. , 2002, Current medicinal chemistry.
[74] A. Kleinfeld,et al. Stopped-flow kinetic analysis of long-chain fatty acid dissociation from bovine serum albumin. , 2002, The Biochemical journal.
[75] A. Cleton,et al. Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[76] D. S. Hage,et al. High-performance affinity chromatography: a powerful tool for studying serum protein binding. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[77] Tomoko Kimura,et al. Binding study of desethyloxybutynin using high-performance frontal analysis method. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[78] R. Kaliszan,et al. Quantitative structure-retention relationships in affinity high-performance liquid chromatography. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[79] J. Schaffer. Fatty acid transport: the roads taken. , 2002, American journal of physiology. Endocrinology and metabolism.
[80] Yukihiro Kuroda,et al. Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis. , 2002, Journal of pharmaceutical and biomedical analysis.
[81] S. Curry,et al. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. , 2001, Journal of molecular biology.
[82] J. B. Pitner,et al. Using receptor conformational change to detect low molecular weight analytes by surface plasmon resonance. , 2001, Analytical chemistry.
[83] Yukihiro Kuroda,et al. Effect of oxidation of low‐density lipoprotein on drug binding affinity studied by high performance frontal analysis‐capillary electrophoresis , 2001, Electrophoresis.
[84] P. Darnerud,et al. Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice , 2001, Archives of Toxicology.
[85] D. S. Hage,et al. Analysis of free drug fractions by ultrafast immunoaffinity chromatography. , 2001, Analytical chemistry.
[86] Yukihiro Kuroda,et al. Role of Biantennary Glycans and Genetic Variants of Human α1-Acid Glycoprotein in Enantioselective Binding of Basic Drugs as Studied by High Performance Frontal Analysis/capillary Electrophoresis , 2001, Pharmaceutical Research.
[87] M. Landoni,et al. Pharmacology of chiral compounds: 2-arylpropionic acid derivatives. , 2001, Current drug metabolism.
[88] D. Greenblatt,et al. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. , 2001, British journal of anaesthesia.
[89] D. S. Hage. Chromatographic and electrophoretic studies of protein binding to chiral solutes. , 2001, Journal of chromatography. A.
[90] S. Curry,et al. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.
[91] A. Gergely,et al. Optical resolution of a series of potential cholecystokinin antagonist 4(3H)-quinazolone derivatives by chiral liquid chromatography on alpha1-acid glycoprotein stationary phase. , 2000, Journal of chromatographic science.
[92] H Roos,et al. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.
[93] Yukihiro Kuroda,et al. Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis. , 2000, Journal of chromatography. A.
[94] D. S. Hage,et al. High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[95] G L Hammond,et al. Crystal structure of human sex hormone‐binding globulin: steroid transport by a laminin G‐like domain , 2000, The EMBO journal.
[96] A. Karlsson,et al. Enantiomeric separation of amino alcohols on protein phases using statistical experimental design. A comparative study. , 2000, Journal of chromatography. A.
[97] Yukihiro Kuroda,et al. Binding analysis of nilvadipine to plasma lipoproteins by capillary electrophoresis-frontal analysis. , 1999, Journal of pharmaceutical and biomedical analysis.
[98] Paul J Thornalley,et al. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.
[99] M. Miyabe,et al. Effect of plasma alpha1-acid glycoprotein concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in infants and children. , 1999, International journal of clinical pharmacology and therapeutics.
[100] R. Kaliszan. Chromatography and capillary electrophoresis in modelling the basic processes of drug action , 1999 .
[101] D. S. Hage,et al. Affinity chromatography: a review of clinical applications. , 1999, Clinical chemistry.
[102] J. McLachlan,et al. Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. , 1999, Environmental health perspectives.
[103] P. Gozzi,et al. Serum protein binding of tolterodine and its major metabolites in humans and several animal species , 1999, Biopharmaceutics & drug disposition.
[104] C. Chambon,et al. Photoaffinity labeling of homologous Met-133 and Met-139 amino acids of rabbit and sheep sex hormone-binding globulins with the unsubstituted Delta 6-testosterone photoreagent. , 1998, Biochemistry.
[105] C. Bertucci,et al. Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties. , 1998, Journal of pharmaceutical and biomedical analysis.
[106] T. Ferenci,et al. Effect of Slow Growth on Metabolism of Escherichia coli, as Revealed by Global Metabolite Pool (“Metabolome”) Analysis , 1998, Journal of bacteriology.
[107] D. S. Hage,et al. Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[108] R. Kaliszan. Retention data from affinity high-performance liquid chromatography in view of chemometrics. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[109] P. Brick,et al. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.
[110] F Baganz,et al. Systematic functional analysis of the yeast genome. , 1998, Trends in biotechnology.
[111] K. Wasan,et al. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. , 1998, Journal of pharmaceutical sciences.
[112] D. S. Hage,et al. Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[113] D. S. Hage,et al. Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: interactions of D- and L-tryptophan with immobilized human serum albumin. , 1997, Journal of chromatography. A.
[114] B. J. Danzo,et al. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. , 1997, Environmental health perspectives.
[115] R. Kaliszan,et al. Quantitative structure-retention relationships in the examination of the topography of the binding site of antihistamine drugs on alpha 1-acid glycoprotein. , 1996, Journal of chromatography. A.
[116] T. Peters,et al. All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .
[117] R. Kaliszan,et al. Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data. , 1995, Biomedical chromatography : BMC.
[118] D. S. Hage,et al. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin. , 1995, Journal of chromatography. B, Biomedical applications.
[119] A. Kleinfeld,et al. Unbound free fatty acid levels in human serum. , 1995, Journal of lipid research.
[120] D. S. Hage,et al. Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. , 1994, Analytical chemistry.
[121] G. Hammond,et al. Steroid-binding and dimerization domains of human sex hormone-binding globulin partially overlap: steroids and Ca2+ stabilize dimer formation. , 1994, Biochemistry.
[122] Roman Kaliszan,et al. CHEMOMETRIC ANALYSIS OF BIOCHROMATOGRAPHIC DATA : IMPLICATIONS FOR MOLECULAR PHARMACOLOGY , 1994 .
[123] A. Buciński,et al. Quantitative relationships between the structure of beta-adrenolytic and antihistamine drugs and their retention on an alpha 1-acid glycoprotein HPLC column. , 1994, Biomedical chromatography : BMC.
[124] Irving W. Wainer,et al. Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases , 1994 .
[125] N. Kerkvliet,et al. Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. , 1994, Toxicology.
[126] D. S. Hage,et al. Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column. , 1993, Journal of chromatography.
[127] P. Pétra,et al. Localization of the steroid‐binding site of the human sex steroid‐binding protein of plasma (SBP or SHBG) by site‐directed mutagenesis , 1992, FEBS letters.
[128] W. P. Purcell,et al. Mechanism of retention of benzodiazepines in affinity, reversed-phase and adsorption high-performance liquid chromatography in view of quantitative structure retention relationships , 1992 .
[129] J. Hermansson,et al. Chiral high-performance liquid chromatographic separations of vinca alkaloid analogues on alpha 1-acid glycoprotein and human serum albumin columns. , 1992, Journal of chromatography.
[130] D. S. Hage,et al. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin. , 1992, Journal of chromatography.
[131] I. Wainer,et al. Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography. , 1992, Molecular pharmacology.
[132] T. Blachère,et al. Characterization of Met-139 as the photolabeled amino acid residue in the steroid binding site of sex hormone binding globulin using delta 6 derivatives of either testosterone or estradiol as unsubstituted photoaffinity labeling reagents. , 1992, Biochemistry.
[133] D. Carter,et al. Atomic structure and chemistry of human serum albumin , 1992, Nature.
[134] D. S. Hage,et al. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. , 1992, Journal of chromatography.
[135] Roman Kaliszan,et al. Quantitative structure-enationselective retention relationships for the chromatography of 1,4-benzodiazepines on a human serum albumin based HPLC chiral stationary phase: An approach to the computational prediction of retention and enantioselectivity , 1992 .
[136] G. Hammond,et al. Structure/function analyses of human sex hormone‐binding globulin by site‐directed mutagenesis , 1992, FEBS letters.
[137] I. Wainer,et al. The in Situ Acetylation of an Immobilized Human Serum Albumin Chiral Stationary Phase for High-Performance Liquid Chromatography in the Examination of Drug–Protein Binding Phenomena , 1992, Pharmaceutical Research.
[138] F. Jamali,et al. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. , 1989, Journal of pharmaceutical sciences.
[139] D. Drayer. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview , 1986, Clinical pharmacology and therapeutics.
[140] T. Kwong. Free drug measurements: methodology and clinical significance. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[141] J. P. Jeanniot,et al. Protein binding of propisomide. , 1985, Journal of pharmaceutical sciences.
[142] Y. Imamura,et al. Effect of simultaneous administration of drugs on absorption and excretion. XIX. Binding of acetohexamide and its major metabolite, (-)-hydroxyhexamide, to human serum albumin. , 1985, Chemical & pharmaceutical bulletin.
[143] A. Lehninger. Principles of Biochemistry , 1984 .
[144] E. Baulieu,et al. Hormonal and immunological aspects of the phylogeny of sex steroid binding plasma protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[145] J. Tillement,et al. The distribution of bound propranolol between the different human serum proteins. , 1980, Molecular pharmacology.
[146] G. Sudlow,et al. Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.
[147] A A Spector,et al. Fatty acid binding to plasma albumin. , 1975, Journal of lipid research.
[148] David C. Anderson,et al. SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.
[149] T. Maung. on in C , 2010 .
[150] M. S. Gonçalves,et al. Fluorescent labeling of biomolecules with organic probes. , 2009, Chemical reviews.
[151] E. Domenici,et al. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. , 2006, Chirality.
[152] Richard A. Lerner,et al. Crystal structure of a bacterial cocaine esterase , 2002, Nature Structural Biology.
[153] J A Sherratt,et al. Lipoprotein oxidation and its significance for atherosclerosis: A mathematical approach , 2002, Bulletin of mathematical biology.
[154] M. Saraste,et al. FEBS Lett , 2000 .
[155] T. Ferenci,et al. Assessing the effect of reactive oxygen species on Escherichia coli using a metabolome approach. , 1999, Redox report : communications in free radical research.
[156] I. Tabas,et al. Nonoxidative modifications of lipoproteins in atherogenesis. , 1999, Annual review of nutrition.
[157] U. Westphal. Steroid-Protein Interactions II , 1986, Monographs on Endocrinology.
[158] N. Tietz,et al. Textbook of clinical chemistry , 1986 .
[159] G. Nelson. Blood Constituents. (Book Reviews: Blood Lipids and Lipoproteins. Quantitation, Composition, and Metabolism) , 1972 .
[160] Ulrich Westphal,et al. Steroid-Protein Interactions , 1971, Monographs on Endocrinology.
[161] H. Kubinyi,et al. Medicinal Chemistry , 1963, Nature.